Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Tilray Inc(TLRY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for TLRY
10/02/2026: TLRY (1-star) is currently NOT-A-BUY. Pass it for now.
Tilray Brands, Inc. is a diversified operator in the cannabis and beverage alcohol sectors, known for a broad portfolio of brands across international markets. Its main business strength lies in its diversified revenue streams, which help offset the volatility inherent in the Canadian cannabis industry. The primary investment story rests on the potential for future U.S. federal cannabis legalization or favorable rescheduling, which could unlock significant growth. Investors face substantial risks including sector-wide regulatory uncertainty, ongoing net losses, and potential equity dilution. The stock is best suited for growth-oriented investors who can tolerate high volatility and hold a long-term view on the evolution of the global cannabis market.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | High growth potential exists if U.S. regulations change, but historical execution has been inconsistent. |
| Momentum investor | Weak fit | The stock often experiences volatile swings tied to regulatory headlines rather than consistent technical trends. |
| Value investor | Weak fit | The company's lack of consistent profitability makes traditional value metrics difficult to justify. |
| Dividend investor | Weak fit | Tilray does not pay a dividend and focuses on cash preservation for growth and operations. |
| Low-risk investor | Weak fit | High volatility and sector-specific regulatory risks make this unsuitable for low-risk portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is highly sensitive to legislative speculation and sector sentiment. |
| Valuation risk | Medium / high | Speculative premiums often detach the share price from fundamental operating metrics. |
| Competition risk (Cannabis/Alcohol) | High | Oversupply in cannabis and saturated alcohol markets pressure margins. |
| Business quality | Medium | The business has successfully diversified but remains structurally unprofitable. |
| Dividend income | Low / none | No income is returned to shareholders via dividends. |
| Execution risk | High | Integrating diverse acquisitions requires significant management bandwidth and efficiency. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -47.67% | Avg. Invested days 14 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/02/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 533.49M USD | Price to earnings Ratio - | 1Y Target Price 7.22 |
Price to earnings Ratio - | 1Y Target Price 7.22 | ||
Volume (30-day avg) 3.7M shares | Beta 1.92 | 52 Weeks Range 3.54 - 23.20 | Updated Date 10/02/2026 |
52 Weeks Range 3.54 - 23.20 | Updated Date 10/02/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.09 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Cannabis Operations | Adult-use and medical cannabis sales, wholesale, and cultivation. | This is the core revenue driver but remains subject to complex regulatory barriers. |
| Beverage Alcohol | Craft breweries and spirits brands. | This segment provides more stable, non-cannabis cash flow for the company. |
| Geography | Canada, Europe, and the United States. | International diversification helps mitigate dependence on any single regulatory market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 1000 | Enterprise Value 761.12M | Price to Sales(TTM) 0.58 |
Enterprise Value 761.12M | Price to Sales(TTM) 0.58 | ||
Enterprise Value to Revenue 0.83 | Enterprise Value to EBITDA 80.67 | Shares Outstanding 147.78M | Shares Floating 133.34M |
Shares Outstanding 147.78M | Shares Floating 133.34M | ||
Percent Insiders 1.59 | Percent Institutions 10.08 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Tilray Inc
Exchange NASDAQ | Headquarters Leamington, ON, Canada | ||
IPO Launch date 2018-07-19 | President, CEO & Chairman Mr. Irwin David Simon | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 3595 | Website https://www.tilray.com |
Full time employees 3595 | Website https://www.tilray.com | ||
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.